Market Place
Sourcing Support
Lantheus Announces Presentation Featuring AZEDRA®
22 Mar 2021 //
BUSINESSWIRE
Lantheus to buy Progenics to chase cancer diagnostics and drugs
03 Oct 2019 //
FIERCE BIOTECH
FDA approves cancer radiation drug Azedra, sending Progenics stock north
31 Jul 2018 //
ENDPTS
Progenics snags FDA nod for $300K ‘ultra-orphan’ cancer-fighter Azedra
31 Jul 2018 //
FIERCE PHARMA
FDA approves first drug to treat rare adrenal cancer
31 Jul 2018 //
PHARMAPHORUM
FDA Approves Progenics Pharma’s Azedra for Ultra-Rare Cancers
31 Jul 2018 //
BIOSPACE
FDA approves Progenics` treatment for rare adrenal gland tumors
31 Jul 2018 //
REUTERS
Progenics Pharma Announces FDA Approval for AZEDRA® (iobenguane I 131)
31 Jul 2018 //
GLOBENEWSWIRE
FDA approves first treatment for rare adrenal tumors
30 Jul 2018 //
PR NEWSWIRE
FDA approves Progenics` treatment for two rare tumors
30 Jul 2018 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.